APA

Zovato S., Kumanova A., Demattè S., Sansovini M., Bodei L., Di Sarra D., Casagranda E., Severi S., Ambrosetti A., Schiavi F., Opocher G. & Paganelli G. (20121213). Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Chicago

Zovato S, Kumanova A, Demattè S, Sansovini M, Bodei L, Di Sarra D, Casagranda E, Severi S, Ambrosetti A, Schiavi F, Opocher G and Paganelli G. 20121213. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Harvard

Zovato S., Kumanova A., Demattè S., Sansovini M., Bodei L., Di Sarra D., Casagranda E., Severi S., Ambrosetti A., Schiavi F., Opocher G. and Paganelli G. (20121213). Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

MLA

Zovato S, Kumanova A, Demattè S, Sansovini M, Bodei L, Di Sarra D, Casagranda E, Severi S, Ambrosetti A, Schiavi F, Opocher G and Paganelli G. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 20121213.